THC Therapeutics Acquires Iconic Oregon Cannabis Brand SugarTop Buddery in $3M All-Share Deal
THC Therapeutics, Inc. has announced its acquisition of SugarTop Buddery, a prominent cannabis brand based in Eugene, Oregon. The transaction, valued at approximately $3 million, was completed through the issuance of newly created Series D Preferred stock. This acquisition enhances THCT's presence in Oregon and supports its strategy to establish a bi-coastal, vertically integrated national cannabis platform. Anna Kaplan, CEO of SugarTop Buddery, expressed optimism about the growth opportunities and the ability to engage new markets on the East Coast. This marks THCT's second strategic acquisition, following its recent purchase of The Headquarters Group. SugarTop Buddery, founded in 2015, is celebrated for its community-driven and music-inspired approach to cannabis, emphasizing artistry, equity, and sustainability.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. THC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-005094), on July 17, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。